» Articles » PMID: 37530788

The Effects of Exercise Dose on Patients with Parkinson's Disease: a Systematic Review and Meta-analysis of Randomized Controlled Trials

Overview
Journal J Neurol
Specialty Neurology
Date 2023 Aug 2
PMID 37530788
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The effects of different exercise doses on motor function, balance, mobility, and quality of life (QOL) in patients with Parkinson's disease (PD) were evaluated.

Method: The exercise intervention dose was evaluated based on the recommendations of the American College of Sports Medicine (ACSM) for developing and maintaining cardiorespiratory health, muscle strength, and physical function for PD patients and classified into high ACSM compliance and low or uncertain ACSM compliance. The impact of ACSM compliance on Unified Parkinson's Disease Rating Scale, Part III (UPDRS-III), Berg Balance Scale (BBS), Timed Up and Go (TUG), and 39-item Parkinson's Disease Questionnaire (PDQ-39) in patients with PD was compared using the standardized mean difference (SMD) along with the corresponding 95% confidence interval (95% CI).

Results: A total of 26 articles were included, comprising 32 studies. Twenty-one studies were classified as high ACSM compliance, and 11 studies were classified as low or uncertain ACSM compliance. For the four outcome measures, the SMD ratio of exercise interventions with high ACSM compliance to those with low or uncertain ACSM compliance was as follows: UPDRS-III (- 0.74: - 0.17), TUG (- 0.62: - 0.17), PDQ-39 (- 0.58: - 0.31), and BBS (0.51: 0.52).

Conclusion: The results suggest that compared with exercise interventions with low or uncertain ACSM compliance, exercise interventions with high ACSM compliance had a more significant improvement effect on motor function, mobility, and QOL in PD patients. However, the effect on balance was not as pronounced, and further research is needed to validate these findings.

Citing Articles

The impact of aerobic exercise dose based on ACSM recommendations on patients with Parkinson's disease: a systematic review and meta-analysis of randomized controlled trials.

Cui W, Hu Z, Li J, Wang S, Xu R Front Aging Neurosci. 2024; 16:1419643.

PMID: 39430975 PMC: 11487601. DOI: 10.3389/fnagi.2024.1419643.


The effects of ACSM-based exercise on breast cancer-related lymphoedema: a systematic review and meta-analysis.

Luan B, Li Z, Yang Q, Xu Z, Chen Y, Wang M Front Physiol. 2024; 15:1413764.

PMID: 39108540 PMC: 11300927. DOI: 10.3389/fphys.2024.1413764.


Optimal dosage ranges of various exercise types for enhancing timed up and go performance in Parkinson's disease patients: a systematic review and Bayesian network meta-analysis.

Yuan Y, Wang J, Wang G, Wang T, Zhang H, Fu X Front Aging Neurosci. 2024; 16:1399175.

PMID: 38988329 PMC: 11234838. DOI: 10.3389/fnagi.2024.1399175.


U.S. Tax Credits to Promote Practical Proactive Preventative Care for Parkinson's Disease.

Okun M J Parkinsons Dis. 2024; 14(2):221-226.

PMID: 38457153 PMC: 10977447. DOI: 10.3233/JPD-240046.


Changes of brain-derived neurotrophic factor (BDNF) levels after different exercise protocols: a systematic review of clinical studies in Parkinson's disease.

Paterno A, Polsinelli G, Federico B Front Physiol. 2024; 15:1352305.

PMID: 38444767 PMC: 10912511. DOI: 10.3389/fphys.2024.1352305.

References
1.
Samii A, Nutt J, Ransom B . Parkinson's disease. Lancet. 2004; 363(9423):1783-93. DOI: 10.1016/S0140-6736(04)16305-8. View

2.
Lew M . Overview of Parkinson's disease. Pharmacotherapy. 2007; 27(12 Pt 2):155S-160S. DOI: 10.1592/phco.27.12part2.155S. View

3.
Kalia L, Lang A . Parkinson's disease. Lancet. 2015; 386(9996):896-912. DOI: 10.1016/S0140-6736(14)61393-3. View

4.
Tysnes O, Storstein A . Epidemiology of Parkinson's disease. J Neural Transm (Vienna). 2017; 124(8):901-905. DOI: 10.1007/s00702-017-1686-y. View

5.
Sveinbjornsdottir S . The clinical symptoms of Parkinson's disease. J Neurochem. 2016; 139 Suppl 1:318-324. DOI: 10.1111/jnc.13691. View